Published in Eur J Pharm Biopharm on February 01, 2008
Preparation and characterization of polysaccharide-based nanoparticles with anticoagulant activity. Int J Nanomedicine (2012) 0.82
A method for concentrating lipid peptide DNA and siRNA nanocomplexes that retains their structure and transfection efficiency. Int J Nanomedicine (2015) 0.78
Relationship between complement activation, cellular uptake and surface physicochemical aspects of novel PEG-modified nanocapsules. Biomaterials (2001) 1.46
Effect of PEO surface density on long-circulating PLA-PEO nanoparticles which are very low complement activators. Biomaterials (1996) 1.03
Complement consumption by poly(ethylene glycol) in different conformations chemically coupled to poly(isobutyl 2-cyanoacrylate) nanoparticles. Life Sci (1997) 0.98
Regulation of the human alternative complement pathway: formation of a ternary complex between factor H, surface-bound C3b and chemical groups on nonactivating surfaces. Eur J Immunol (1989) 0.94
Controlling the cohesion of cement paste. Langmuir (2005) 0.91
Thrombosis of angiographic catheters in humans: experimental study. Int J Artif Organs (1999) 0.90
Interactions of nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate) with the complement system. Life Sci (1998) 0.89
Periodate oxidation of sodium alginate in water and in ethanol-water mixture: a comparative study. Carbohydr Res (2005) 0.89
Long-circulating nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate). Pharm Res (1998) 0.88
Ca/Na montmorillonite: structure, forces and swelling properties. Langmuir (2010) 0.83
Regulation by sulphonate groups of complement activation induced by hydroxymethyl groups on polystyrene surfaces. Biomaterials (1993) 0.82
The ability of Sephadex to activate human complement is suppressed in specifically substituted functional Sephadex derivatives. Mol Immunol (1988) 0.82
Dips and rims in dried colloidal films. Phys Rev Lett (2010) 0.81
Interactions of poly(lactic acid) and poly(lactic acid-co-ethylene oxide) nanoparticles with the plasma factors of the coagulation system. Biomaterials (1997) 0.81
Oxidized chondroitin sulfate-cross-linked gelatin matrixes: a new class of hydrogels. Biomacromolecules (2005) 0.80
Anticoagulant effects of sulphonated polyurethanes. Biomaterials (1992) 0.80
Interactions of functionalized polystyrene derivatives with the complement system in human serum. J Biomater Sci Polym Ed (1991) 0.80
A new generation of polymer nanoparticles for drug delivery. Cell Mol Biol (Noisy-le-grand) (2004) 0.80
Structures of nanoparticles prepared from oil-in-water emulsions. Pharm Res (1995) 0.79
Rheology and phase behavior of dense casein micelle dispersions. J Chem Phys (2009) 0.79
Onset of cohesion in cement paste. Langmuir (2004) 0.79
Heparin-like activity of insoluble sulphonated polystyrene resins. Part III: Binding of dicarboxylic amino acids. Biomaterials (1987) 0.78
Transformation of Aspergillus flavus: construction of urate oxidase-deficient mutants by gene disruption. Curr Genet (1992) 0.78
Heparin-like functionalized polymer surfaces: discrimination between catalytic and adsorption processes during the course of thrombin inhibition. Biomaterials (1996) 0.78
Reduction of the uptake by a macrophagic cell line of nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate). J Drug Target (2000) 0.78
Hydration of an amphiphilic excipient, Gelucire 44/14. Int J Pharm (2004) 0.77
Specific interactions of polystyrene biomaterials with factor D of human complement. Biomaterials (1993) 0.77
[Evolution of the pelvis and hip throughout history: from primates to modern man]. J Radiol (2011) 0.77
Relationship between reduction of complement activation by polysaccharide surfaces bearing diethylaminoethyl groups and their degree of substitution. Biomaterials (1995) 0.76
Interactions between human plasma proteins and heparin-poly(methyl methacrylate) copolymer. Thromb Haemost (1979) 0.76
Preparation and characterization of nanoparticles bearing heparin or dextran covalently-linked to poly(methyl methacrylate). J Biomater Sci Polym Ed (1999) 0.76
Complement activation and adsorption of protein fragments by functionalized polymer surfaces in human serum. Biomaterials (1992) 0.76
Equation of state of colloidal dispersions. Langmuir (2011) 0.76
Reactivity, swelling and aggregation of mixed-size silicate nanoplatelets. Nanoscale (2015) 0.75
Specific antibodies enhance Sephadex-induced activation of the alternative complement pathway in human serum. Biomaterials (1988) 0.75
Genetic improvements of an industrial strain of Aspergillus flavus for urate oxidase production. J Biotechnol (1993) 0.75
Restructuring of colloidal cakes during dewatering. Langmuir (2007) 0.75
Activation of the complement system by polysaccharidic surfaces bearing carboxymethyl, carboxymethylbenzylamide and carboxymethylbenzylamide sulphonate groups. Biomaterials (1995) 0.75
Small-angle neutron scattering study of particle coalescence and SDS desorption during film formation from carboxylated acrylic latices. J Colloid Interface Sci (2003) 0.75
[Study of a Pseudomonas mutant altered in methanol metabolism]. Z Allg Mikrobiol (1979) 0.75
Properties of heparin--poly(methyl methacrylate) copolymers. II. J Biomed Mater Res (1977) 0.75
Interaction of nanometric clay platelets. Langmuir (2008) 0.75
Nature of flocculation and tactoid formation in montmorillonite: the role of pH. Phys Chem Chem Phys (2015) 0.75
Haemocompatibility of polyethylene-polystyrene modified tubings. Life Support Syst (1983) 0.75
The role of interparticle forces in colloidal aggregates: local investigations and modelling of restructuring during filtration. Water Sci Technol (2006) 0.75
ESCA studies on heparin-like materials used for extracorporeal shunts. Int J Artif Organs (1982) 0.75
Patents and literature. Appl Biochem Biotechnol (1982) 0.75
[The chronically limping child]. J Radiol (2011) 0.75
Plasmatic antiproteinase activity enhancement by insoluble functionalized polystyrene surfaces. Biomaterials (1990) 0.75
Catalytic activity and platelet reactivity of heparin covalently bonded to surfaces. J Lab Clin Med (1985) 0.75
Diffusion MRI of the neck of the femur in Legg-Calve-Perthes disease: a preliminary study. Diagn Interv Imaging (2012) 0.75
Heparin-like activity of insoluble sulphonated polystyrene resins. Part I: Influence of the surface density, nature and binding of substituted anionic groups. Biomaterials (1985) 0.75
Phase transition pathways for the production of 100 nm oil-in-water emulsions. Phys Chem Chem Phys (2008) 0.75
Determining the microbiological criteria for lot rejection from the performance objective or food safety objective. Int J Food Microbiol (2006) 0.75